We observed significant downregulation of ADAMTS9‐AS2, WDFY3‐AS2, RP11‐295M3.4, RP11‐490M8.1, and CTB‐92J24.3 and significant overexpression of FAM83H‐AS1 in breast cancer. Here, WDFY3 is linked to breast carcinoma.